Sally W. Schwarz

1.9k total citations
42 papers, 1.2k citations indexed

About

Sally W. Schwarz is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sally W. Schwarz has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Sally W. Schwarz's work include Radiopharmaceutical Chemistry and Applications (25 papers), Medical Imaging Techniques and Applications (21 papers) and Medical Imaging and Pathology Studies (9 papers). Sally W. Schwarz is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (25 papers), Medical Imaging Techniques and Applications (21 papers) and Medical Imaging and Pathology Studies (9 papers). Sally W. Schwarz collaborates with scholars based in United States, Austria and Ireland. Sally W. Schwarz's co-authors include Carolyn J. Anderson, Paul Cutler, Jason S. Lewis, Farrokh Dehdashti, Gordon W. Philpott, Judith M. Connett, Richard Laforest, Kurt R. Zinn, Laura A. Bass and D. W. Mccarthy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Sally W. Schwarz

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally W. Schwarz United States 16 957 362 330 177 123 42 1.2k
Laura A. Bass United States 13 1.1k 1.1× 430 1.2× 344 1.0× 186 1.1× 231 1.9× 15 1.5k
Mickaël Bourgeois France 22 648 0.7× 319 0.9× 200 0.6× 97 0.5× 189 1.5× 45 996
Ute Hennrich Germany 8 717 0.7× 436 1.2× 474 1.4× 195 1.1× 181 1.5× 12 1.1k
Joseph E. Bugaj United States 15 529 0.6× 248 0.7× 191 0.6× 183 1.0× 250 2.0× 34 1.1k
Konstantin Zhernosekov Germany 19 1.3k 1.4× 492 1.4× 607 1.8× 357 2.0× 125 1.0× 33 1.7k
A. Bogni Italy 21 841 0.9× 312 0.9× 228 0.7× 139 0.8× 243 2.0× 44 1.4k
J.F. Chatal France 19 1.0k 1.1× 391 1.1× 246 0.7× 141 0.8× 234 1.9× 49 1.4k
Peter Roselt Australia 25 980 1.0× 541 1.5× 337 1.0× 169 1.0× 362 2.9× 71 1.7k
Jin Sook Ryu South Korea 22 732 0.8× 198 0.5× 291 0.9× 131 0.7× 168 1.4× 57 1.9k
Jacek Koziorowski Sweden 18 671 0.7× 154 0.4× 196 0.6× 83 0.5× 153 1.2× 38 987

Countries citing papers authored by Sally W. Schwarz

Since Specialization
Citations

This map shows the geographic impact of Sally W. Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally W. Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally W. Schwarz more than expected).

Fields of papers citing papers by Sally W. Schwarz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally W. Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally W. Schwarz. The network helps show where Sally W. Schwarz may publish in the future.

Co-authorship network of co-authors of Sally W. Schwarz

This figure shows the co-authorship network connecting the top 25 collaborators of Sally W. Schwarz. A scholar is included among the top collaborators of Sally W. Schwarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally W. Schwarz. Sally W. Schwarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Dong, Wenhua Chu, Jinbin Xu, Sally W. Schwarz, & John A. Katzenellenbogen. (2023). [18F]Tosyl fluoride as a versatile [18F]fluoride source for the preparation of 18F-labeled radiopharmaceuticals. Scientific Reports. 13(1). 3182–3182. 3 indexed citations
2.
Lee, Hsiaoju, Sally W. Schwarz, Erin K. Schubert, et al.. (2022). The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1. Radiology Imaging Cancer. 4(1). e210070–e210070. 14 indexed citations
3.
Flores, Shaney, Charles D. Chen, Yi Su, et al.. (2022). Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease. Journal of Nuclear Medicine. 64(2). 287–293. 12 indexed citations
4.
Laforest, Richard, Anchal Ghai, Tyler J. Fraum, et al.. (2022). First-in-Humans Evaluation of Safety and Dosimetry of64Cu-LLP2A for PET Imaging. Journal of Nuclear Medicine. 64(2). 320–328. 16 indexed citations
5.
Zhou, Dong, Sally W. Schwarz, & John A. Katzenellenbogen. (2021). Determination of molar activity of [18F]fluoride by HPLC via sulfonyl derivatization. Applied Radiation and Isotopes. 176. 109865–109865. 3 indexed citations
6.
Schwarz, Sally W., et al.. (2018). Harmonization of U.S., European Union, and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals: Is This Possible?. Journal of Nuclear Medicine. 60(2). 158–166. 17 indexed citations
7.
Bormans, Guy, Andreas K. Buck, Arturo Chiti, et al.. (2017). Position statement on radiopharmaceutical production for clinical trials. EJNMMI Radiopharmacy and Chemistry. 2(1). 12–12. 6 indexed citations
8.
Gordon, Leonie, et al.. (2016). Working Together to Advance Women in Nuclear Medicine.. PubMed. 57(9). 14N–14N. 1 indexed citations
9.
Schwarz, Sally W., et al.. (2015). The Role of Exploratory Investigational New Drugs for Translating Radiopharmaceuticals into First-in-Human Studies. Journal of Nuclear Medicine. 56(4). 497–500. 5 indexed citations
10.
Schwarz, Sally W., David Dick, Henry F. VanBrocklin, & John M. Hoffman. (2014). Regulatory Requirements for PET Drug Production. Journal of Nuclear Medicine. 55(7). 1132–1137. 25 indexed citations
11.
Schwarz, Sally W., Jeffrey P. Norenberg, Marc S. Berridge, et al.. (2012). The Future of USP Monographs for PET Drugs. Journal of Nuclear Medicine. 54(3). 472–475. 4 indexed citations
12.
Decristoforo, Clemens & Sally W. Schwarz. (2011). Radiopharmacy: regulations and legislations in relation to human applications. Drug Discovery Today Technologies. 8(2-4). e71–e77. 5 indexed citations
13.
Norenberg, Jeffrey P., Neil A. Petry, & Sally W. Schwarz. (2010). Operation of a Radiopharmacy for a Clinical Trial. Seminars in Nuclear Medicine. 40(5). 347–356. 7 indexed citations
14.
Laforest, Richard, Farrokh Dehdashti, Jason S. Lewis, & Sally W. Schwarz. (2005). Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET. European Journal of Nuclear Medicine and Molecular Imaging. 32(7). 764–770. 75 indexed citations
15.
Lewis, Jason S., Michael R. Lewis, Paul Cutler, et al.. (1999). Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.. PubMed. 5(11). 3608–16. 92 indexed citations
16.
Cutler, Paul, Sally W. Schwarz, Carolyn J. Anderson, et al.. (1995). Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso.. PubMed. 36(12). 2363–71. 31 indexed citations
17.
McCarthy, Timothy J., Sally W. Schwarz, & Michael J. Welch. (1994). Nuclear Medicine and Positron Emission Tomography: An Overview. Journal of Chemical Education. 71(10). 830–830. 19 indexed citations
18.
Schwarz, Sally W., Judith M. Connett, Carolyn J. Anderson, et al.. (1994). Evaluation of a direct method for technetium labeling intact and F(ab′)2 1A3, an anticolorectal monoclonal antibody. Nuclear Medicine and Biology. 21(4). 619–626. 2 indexed citations
19.
Anderson, Carolyn J., Judith M. Connett, Sally W. Schwarz, et al.. (1992). Copper-64-labeled antibodies for PET imaging.. PubMed. 33(9). 1685–91. 118 indexed citations
20.
Schwarz, Sally W., C.J. Mathias, Jie Sun, et al.. (1991). Evaluation of two new bifunctional chelates for radiolabeling a parathyroid-specific monoclonal antibody with In-111. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(5). 477–481. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura A. Bass Breakdown of academic impact, for papers by Mickaël Bourgeois Breakdown of academic impact, for papers by Ute Hennrich Breakdown of academic impact, for papers by Joseph E. Bugaj Breakdown of academic impact, for papers by Konstantin Zhernosekov Breakdown of academic impact, for papers by A. Bogni Breakdown of academic impact, for papers by J.F. Chatal Breakdown of academic impact, for papers by Peter Roselt Breakdown of academic impact, for papers by Jin Sook Ryu Breakdown of academic impact, for papers by Jacek Koziorowski
Rankless by CCL
2026